Relmada Therapeutics, Inc. · NASDAQ:RLMD

Squadron Capital Management LLC's stake in Relmada Therapeutics, Inc. fell to 3.30% (Schedule 13G/A)

Event Sep 30, 2026 · Filed Nov 16, 2026

Squadron Capital Management LLC's stake in Relmada Therapeutics, Inc. fell to 3.30%, 3,500,000 shares, as a passive investor on Sep 30, 2026. Filed Nov 16, 2026 (Schedule 13G/A).

Stake
3.30%
Shares
3,500,000
Intent
Passive
What changed
Fell below 5%
Filed together
4 holders

The filing in full

HolderStakeShares
Squadron Master Fund LP3.30%3,500,000
Squadron Capital Management LLC3.30%3,500,000
Matthew Sesterhenn3.30%3,500,000
William Blank3.30%3,500,000

Source

Download original · View original at SEC

Related